New drug aims to tame Sjögren's Flare-Ups in major trial
NCT ID NCT07404865
First seen Feb 18, 2026 · Last updated May 22, 2026 · Updated 18 times
Summary
This phase 3 study tests whether telitacicept can reduce disease activity in adults with active primary Sjögren's disease. About 250 participants will receive either the drug or a placebo for 48 weeks. The main goal is to see if telitacicept improves symptoms like dry eyes and mouth by calming the immune system.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for PRIMARY SJOGREN'S DISEASE are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Accurate Clinical Research
RECRUITINGBaytown, Texas, 77521, United States
-
Accurate Clinical Research, Inc.
RECRUITINGLake Charles, Louisiana, 70605, United States
-
Accurate Clinical Research, Inc.
RECRUITINGHouston, Texas, 77089, United States
-
Allen Arthritis
RECRUITINGAllen, Texas, 75013, United States
-
Altoona Center for Clinical Research, P.C.
RECRUITINGDuncansville, Pennsylvania, 16635, United States
-
Arizona Arthritis & Rheumatology Associates P.C.
RECRUITINGChandler, Arizona, 85225, United States
-
Arizona Arthritis & Rheumatology Associates P.C.
RECRUITINGFlagstaff, Arizona, 86001, United States
-
Arizona Arthritis & Rheumatology Associates P.C.
RECRUITINGPhoenix, Arizona, 85392, United States
-
Arizona Arthritis & Rheumatology Associates, P.C.
RECRUITINGTucson, Arizona, 85704, United States
-
Arizona Arthritis & Rheumatology Associates, PLLC
RECRUITINGGlendale, Arizona, 85306, United States
-
Arthritis and Rheumatism Associates
RECRUITINGRockville, Maryland, 20850, United States
-
Arthritis and Rheumatology Research Institute, PLLC
RECRUITINGAllen, Texas, 75013, United States
-
Chicago Clinical Research Institute Inc
RECRUITINGChicago, Illinois, 60607, United States
-
Clinical Investigation Specialist
RECRUITINGSchaumburg, Illinois, 60195, United States
-
Finlay Medical Research Corp
RECRUITINGGreen Acres, Florida, 33467, United States
-
Lone Star Arthritis & Rheumatology
RECRUITINGFort Worth, Texas, 76109, United States
-
Novel Research LLC
RECRUITINGBellaire, Texas, 77401, United States
-
Precision Comprehensive Clinical Research Solutions
RECRUITINGEuless, Texas, 76040, United States
-
R&H Clinical Research Inc.
RECRUITINGKaty, Texas, 77450, United States
-
Suncoast Clinical Research Inc.
RECRUITINGNew Port Richey, Florida, 34652, United States
-
Tidewater Clinical Research
RECRUITINGChesapeake, Virginia, 23320, United States
-
Velocity Clinical Research, Waco
RECRUITINGWaco, Texas, 76710, United States
-
Wallace Rheumatic Study Center
RECRUITINGBeverly Hills, California, 90210, United States
-
Willow Rheumatology & Wellness
RECRUITINGWillowbrook, Illinois, 60527, United States
Conditions
Explore the condition pages connected to this study.